Imigran FDT

Imigran FDT





Zuellig Pharma
Concise Prescribing Info
Sumatriptan succinate
Acute relief of migraine w/ or w/o aura including migraine attacks associated w/ menstrual period.
Dosage/Direction for Use
Adult Single 50 or 100 mg dose. If no response to 1st dose, 2nd dose should not be taken for the same attack. If patient responded to the 1st dose, but symptoms recur, 2nd dose may be given in the next 24 hr provided not >300 mg is taken in any 24-hr period.
May be taken with or without food: Swallow whole. For patients w/ swallowing difficulties, disperse tab in a small amount of water.
Hypersensitivity. Previous MI, ischaemic heart disease (IHD), Prinzmetal's angina/coronary vasospasm, peripheral vascular disease or patients who have symptoms or signs consistent w/ IHD. History of CVA or transient ischaemic attack. Uncontrolled HTN, severe hepatic impairment. Concomitant therapy w/ MAOIs, ergotamine or its derivatives.
Special Precautions
Potentially serious neurological conditions underlying CV disease. Hypersensitivity to sulphonamides. Controlled HTN. Hepatic or renal impairment. History of seizures, lowered seizure threshold. May affect ability to drive or operate machinery. Pregnancy & lactation. Childn. Elderly >65 yr.
Adverse Reactions
Dizziness, drowsiness, paraesthesia, hypoaesthesia; transient increase in BP, flushing; dyspnoea; nausea & vomiting; sensations of heaviness; pain, sensations of heat or cold, pressure or tightness; weakness, fatigue.
Drug Interactions
Not to be given w/ ergotamine, MAOIs. Serotonin syndrome w/ SSRI/selective nonadrenaline reuptake inhibitors. Not recommended w/ 5HT1 agonist.
MIMS Class
Antimigraine Preparations
ATC Classification
N02CC01 - sumatriptan ; Belongs to the class of selective serotonin (5HT1) agonists preparations. Used to relieve migraine.
Imigran FDT tab 100 mg
Imigran FDT tab 50 mg
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in